Articles about Adaptive

Tech Moves: Adaptive Biotechnologies COO departing; Sana adds leaders; and more

— Mark Adams is stepping down as chief operating officer of Adaptive Biotechnologies, the company said today in a regulatory… Read More

Adaptive Biotechnologies reports $38.6M in Q1 revenue as it repositions following job cuts

Adaptive Biotechnologies announced its first quarter earnings Wednesday, two months after laying off 12% of its workforce. The public Seattle… Read More

Tech stocks soar in 2020 amid pandemic as Seattle-area companies see valuations spike

2020 was a big year for big tech on Wall Street. Despite parts of the economy shuttering due to COVID-19,… Read More

Universal blood test from Microsoft and Adaptive is a Google-sized data challenge

A novel effort from Microsoft and Adaptive Biotechnologies to diagnose multiple diseases from a single blood test is a data… Read More

Adaptive Biotechnologies files for $230M IPO, banking on big Microsoft and Genentech deals

Adaptive Biotechnologies, a high-flying startup that makes technology to read the human immune system, has officially filed to go public… Read More

Fast-growing Adaptive Biotechnologies appoints president of new therapeutics division

Adaptive Biotechnologies, the heavily-funded Seattle bioinformatics company, today announced that Diego Miralles will become the president of a new division of… Read More

Seattle’s Adaptive Biotechnologies raises whopping $195 million venture round

In the largest venture capital round in Washington state so far this year, Adaptive Biotechnologies has scored $195 million in… Read More

Tech Moves: Vern Fotheringham named CEO of satellite venture; Paul Shoemaker leaving SVP after 17 years; and more

—Telecommunications entrepreneur Vern Fotheringham has been named CEO of Leosat, an Arlington, Virginia-based company developing a constellation of low-earth orbit… Read More